Rite Aid is in a extremely bearish downtrend pre earnings.

The recent reverse split has not helped the stock, it just makes the stock even worse from a technical perspective. There is really nothing to cling your hopes to on the chart, the only positive is that it is so bad that any earnings surprise could produce a great bounce, but just because the stock price is low does not mean it is cheap.

AVERAGE ANALYSTS PRICE TARGET $6.50
AVERAGE ANALYSTS RECOMMENDATION UNDERWEIGHT

COMPANY PROFILE
Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through the Retail Pharmacy and Pharmacy Services business segments. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass in September 1962 and is headquartered in Camp Hill, PA.